2.08
price down icon1.89%   -0.04
pre-market  Vorhandelsmarkt:  2.08  
loading
Schlusskurs vom Vortag:
$2.12
Offen:
$2.09
24-Stunden-Volumen:
258.43K
Relative Volume:
0.51
Marktkapitalisierung:
$169.85M
Einnahmen:
$3.91M
Nettoeinkommen (Verlust:
$-206.53M
KGV:
-0.8379
EPS:
-2.4825
Netto-Cashflow:
$-167.78M
1W Leistung:
-0.95%
1M Leistung:
-16.80%
6M Leistung:
+94.39%
1J Leistung:
+46.48%
1-Tages-Spanne:
Value
$2.0107
$2.12
1-Wochen-Bereich:
Value
$2.0107
$2.25
52-Wochen-Spanne:
Value
$0.595
$3.075

I Mab Adr Stock (IMAB) Company Profile

Name
Firmenname
I Mab Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
32
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
IMAB's Discussions on Twitter

Vergleichen Sie IMAB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IMAB
I Mab Adr
2.08 171.49M 3.91M -206.53M -167.78M -2.4825
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

I Mab Adr Stock (IMAB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-12-09 Eingeleitet Siebert Williams Shank Buy
2021-06-02 Eingeleitet Daiwa Securities Buy
2021-03-15 Eingeleitet Needham Buy
2021-03-03 Bestätigt H.C. Wainwright Buy
2021-02-25 Eingeleitet Piper Sandler Overweight
2020-12-07 Eingeleitet H.C. Wainwright Buy
2020-07-27 Eingeleitet Cantor Fitzgerald Overweight
2020-02-12 Eingeleitet China Renaissance Buy
2020-02-11 Eingeleitet Jefferies Buy
Alle ansehen

I Mab Adr Aktie (IMAB) Neueste Nachrichten

pulisher
Jul 17, 2025

I-Mab acquires Bridge Health to strengthen givastomig development By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

I-Mab acquires Bridge Health to strengthen givastomig development - Investing.com India

Jul 17, 2025
pulisher
Jul 16, 2025

Best Income Stocks to Buy for July 16th - The Globe and Mail

Jul 16, 2025
pulisher
Jul 14, 2025

I-Mab to Present at the BTIG Virtual Biotechnology Conference - GlobeNewswire Inc.

Jul 14, 2025
pulisher
Jul 11, 2025

I-MAB files 6-K to amend US$21M ADS shelf registration | BQ SEC FilingForm 6-K - Stock Titan

Jul 11, 2025
pulisher
Jul 02, 2025

I-Mab reports 83% response rate for givastomig in gastric cancer study - Investing.com India

Jul 02, 2025
pulisher
Jun 30, 2025

I-Mab’s givastomig shows promising results in gastric cancer study - Investing.com

Jun 30, 2025
pulisher
Jun 27, 2025

I-Mab stock maintains buy rating at H.C. Wainwright on strong cancer data - Investing.com

Jun 27, 2025
pulisher
Jun 26, 2025

I-Mab reports 71% response rate for gastric cancer drug in trial - Investing.com

Jun 26, 2025
pulisher
Jun 24, 2025

H.C. Wainwright reiterates buy rating on I-Mab stock ahead of key data - Investing.com

Jun 24, 2025
pulisher
Jun 17, 2025

I-Mab at H.C. Wainwright: Strategic Shift Towards U.S. Operations - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

I-Mab at H.C. Wainwright: Strategic Shift Towards U.S. Operations By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Market Momentum: Abpro Holdings Inc (ABP) Registers a 3.72 Increase, Closing at 0.22 - DWinneX

Jun 17, 2025
pulisher
Jun 17, 2025

Unity Software Inc’s Market Journey: Closing Strong at 24.40, Up 3.13 - DWinneX

Jun 17, 2025
pulisher
Jun 13, 2025

I-Mab Sponsored ADR (IMAB)'s Technical Outlook is Bright After Key Golden Cross - MSN

Jun 13, 2025
pulisher
Jun 12, 2025

I-Mab regains Nasdaq compliance as shares maintain $1 minimum bid - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement - Yahoo Finance

Jun 12, 2025
pulisher
Jun 11, 2025

Figure 1. Protein and mRNA expressions of P-glycoprotein in BEL-7402... - researchgate.net

Jun 11, 2025
pulisher
Jun 11, 2025

Willdan Group, Inc.'s (NASDAQ:WLDN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Can This Unstoppable Stock Join Microsoft, Nvidia, Apple, Amazon, Alphabet, Meta Platforms, and Tesla in the $1 Trillion Club? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

Graphjet Technology Discloses Notice from Nasdaq - Yahoo Finance

Jun 10, 2025
pulisher
Jun 07, 2025

B. Riley Financial granted extension from Nasdaq regarding listing rules - Yahoo Finance

Jun 07, 2025
pulisher
Jun 06, 2025

I-Mab Sponsored ADR (IMAB) is a Great Momentum Stock: Should You Buy? - sharewise

Jun 06, 2025
pulisher
Jun 06, 2025

All You Need to Know About PTC Therapeutics (PTCT) Rating Upgrade to Buy - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

Asian Stocks Shine As Biotech And Financials Lead Gains - Finimize

Jun 05, 2025
pulisher
Jun 05, 2025

Lyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study Success - Yahoo Finance

Jun 05, 2025
pulisher
Jun 03, 2025

I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series - Yahoo Finance

Jun 03, 2025
pulisher
May 28, 2025

I-Mab stock surges on Lucid Capital’s buy rating initiation By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 28, 2025

I-Mab stock surges on Lucid Capital’s buy rating initiation - Investing.com

May 28, 2025
pulisher
May 28, 2025

Lucid Capital sets I-Mab stock Buy rating, $5 target on cancer drug potential - Investing.com

May 28, 2025
pulisher
May 17, 2025

I-Mab’s Financial Report Highlights Givastomig Progress - TipRanks

May 17, 2025
pulisher
May 15, 2025

I-Mab Reports First Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

May 15, 2025
pulisher
May 06, 2025

I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023 - Barchart.com

May 06, 2025
pulisher
May 05, 2025

I-Mab Announces Publication of Claudin18.2 x 4-1BB Bispecific Antibody Givastomig in JITC - Barchart.com

May 05, 2025
pulisher
Apr 14, 2025

After Plunging -20.33% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB) - Yahoo Finance

Apr 14, 2025
pulisher
Apr 11, 2025

After Plunging -19.7% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB) - Yahoo Finance

Apr 11, 2025
pulisher
Apr 07, 2025

I-Mab at Needham Conference: Strategic Transformation Unveiled - Investing.com

Apr 07, 2025
pulisher
Apr 07, 2025

I-Mab at Needham Conference: Strategic Transformation Unveiled By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 04, 2025

I-Mab’s Transformative Year: Financial and Strategic Highlights - TipRanks

Apr 04, 2025
pulisher
Apr 04, 2025

I-Mab stock price target lowered to $7 at H.C. Wainwright By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

I-Mab stock price target lowered to $7 at H.C. Wainwright - Investing.com India

Apr 04, 2025
pulisher
Apr 03, 2025

I-Mab stock touches 52-week low at $0.72 amid market challenges - Investing.com

Apr 03, 2025
pulisher
Mar 21, 2025

I-Mab faces Nasdaq delisting over bid price rule By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

I-Mab faces Nasdaq delisting over bid price rule - Investing.com

Mar 21, 2025
pulisher
Mar 07, 2025

I-Mab advances gastric cancer treatment with swift trial enrollment - Investing.com

Mar 07, 2025
pulisher
Mar 05, 2025

I-Mab stock touches 52-week low at $0.76 amid market challenges - Investing.com India

Mar 05, 2025

Finanzdaten der I Mab Adr-Aktie (IMAB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):